Associations between butane hash oil use and cannabis-related problems

Drug and Alcohol Dependence

Volumn 179, Issue , 2017, Pages 25-31

  Meier, Madeline H ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Butane hash oil; Cannabis; Cannabis dependence; Concentrate; Dabs; Marijuana

Indexed keywords

BUTANE; BUTANE HASH OIL; UNCLASSIFIED DRUG; CANNABIS; OIL;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CANNABIS ADDICTION; CANNABIS USE; COLLEGE STUDENT; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL DISEASE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SELF CARE; SELF CONCEPT; SOCIAL PROBLEM; SUBSTANCE USE; YOUNG ADULT; DRUG DEPENDENCE; PSYCHOLOGY; PSYCHOSIS; UNITED STATES;

BUTANES; CANNABIS; HUMANS; MARIJUANA ABUSE; OILS; PSYCHOTIC DISORDERS; SELF CONCEPT; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 85025127988     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2017.06.015     Document Type: Article

References (51)

1. Atkins, D.C., Baldwin, S.A., Zheng, C., Gallop, R.J., Neighbors, C., A tutorial on count regression and zero-altered count models for longitudinal substance use data. Psychol. Addict. Behav. 27 (2013), 166–177.
2. Bell, C., Slim, J., Flaten, H.K., Lindberg, G., Arek, W., Monte, A.A., Butane hash oil burns associated with marijuana liberalization in Colorado. J. Med. Toxicol. 11 (2015), 422–425.
3. Buckner, J.D., Zvolensky, M.J., Crosby, R.D., Wonderlich, S.A., Ecker, A.H., Richter, A., Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from ecological momentary assessment. Drug Alcohol Depend. 147 (2015), 20–25.
4. Budney, A.J., Vandrey, R.G., Hughes, J.R., Thostenson, J.D., Bursac, Z., Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J. Subst. Abuse Treat. 35 (2008), 362–368.
5. Cavazos-Rehg, P.A., Sowles, S.J., Krauss, M.J., Agbonavbare, V., Grucza, R., Bierut, L., A content analysis of tweets about high-potency marijuana. Drug Alcohol Depend. 166 (2016), 100–108.
6. Cerdá, M., Moffitt, T.E., Meier, M.H., Harrington, H., Houts, R., Ramrakha, S., Hogan, S., Poulton, R., Caspi, A., Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: a longitudinal cohort study. Clin. Psychol. Sci. 4 (2016), 1028–1046.
7. Chait, L.D., Burke, K.A., Preference for high- versus low-potency marijuana. Pharmacol. Biochem. Behav. 49 (1994), 643–647.
8. Chen, K., Kandel, D.B., Davies, M., Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug Alcohol Depend. 46 (1997), 53–67.
9. Chen, C.Y., O'Brien, M.S., Anthony, J.C., Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001. Drug Alcohol Depend. 79 (2005), 11–22.
10. Chung, T., Martin, C.S., Cornelius, J.R., Clark, D.B., Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. Addiction 103 (2008), 787–799.
11. Curran, H.V., Freeman, T.P., Mokrysz, C., Lewis, D.A., Morgan, C.J., Parsons, L.H., Keep off the grass? Cannabis, cognition and addiction. Nat. Rev. Neurosci. 17 (2016), 293–306.
12. Daniulaityte, R., Nahhas, R.W., Wijeratne, S., Carlson, R.G., Lamy, F.R., Martins, S.S., Boyer, E.W., Smith, G.A., Sheth, A., Time for dabs: analyzing Twitter data on marijuana concentrates across the US. Drug Alcohol Depend. 155 (2015), 307–311.
13. Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T.R., Handley, R., Luzi, S., Russo, M., Paparelli, A., Butt, A., Stilo, S.A., Wiffen, B., Powell, J., Murray, R.M., High-potency cannabis and the risk of psychosis. Br. J. Psychiatry 195 (2009), 488–491.
14. Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O'Connor, J., Russo, M., Stilo, S.A., Marques, T.R., Mondelli, V., Dazzan, P., Pariante, C., David, A.S., Gaughran, F., Atakan, Z., Iyegbe, C., Powell, J., Morgan, C., Lynskey, M., Murray, R.M., Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry 2 (2015), 233–238.
15. ElSohly, M.A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., Church, J.C., Changes in cannabis potency over the last two decades (1995–2014): analysis of current data in the United States. Biol. Psychiatry 79 (2016), 613–619.
16. Englund, A., Morrison, P.D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., Stone, J.M., Reichenberg, A., Brenneisen, R., Holt, D., Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J. Psychopharmacol. 27 (2013), 19–27.
17. Englund, A., Freeman, T.P., Murray, R.M., McGuire, P., Can we make cannabis safer?. Lancet Psychiatry, 2017, 10.1016/s2215-0366(17)30075-5.
18. Freeman, T., Winstock, A., Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol. Med. 45 (2015), 3181–3189.
19. Freeman, T.P., Morgan, C.J., Hindocha, C., Schafer, G., Das, R.K., Curran, H.V., Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?. Addiction 109 (2014), 1686–1694.
20. Hall, W., What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?. Addiction 110 (2015), 19–35.
21. Hallfors, D.D., Saxe, L., The dependence potential of short half-life benzodiazepines: a meta-analysis. Am. J. Public Health 83 (1993), 1300–1304.
22. Harder, V.S., Stuart, E.A., Anthony, J.C., Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol. Methods 15 (2010), 234–249.
23. Hirvonen, J., Goodwin, R.S., Li, C.T., Terry, G.E., Zoghbi, S.S., Morse, C., Pike, V.W., Volkow, N.D., Huestis, M.A., Innis, R.B., Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol. Psychiatry 17 (2012), 642–649.
24. Hoyle, R.H., Stephenson, M.T., Palmgreen, P., Lorch, E.P., Donohew, R.L., Reliability and validity of a brief measure of sensation seeking. Pers. Individ. Diff. 32 (2002), 401–414.
25. Johnston, L.D., O'Malley, P.M., Bachman, J.G., Schulenberg, J.E., Miech, R.A., Monitoring the Future National Survey Results on Drug Use, 1975–2015: Volume 2, College Students and Adults Ages 19–55. 2016, The University of Michigan, Ann Arbor: Institute for Social Research.
26. Jones, C.B., Hill, M.L., Pardini, D.A., Meier, M.H., Prevalence and correlates of vaping cannabis in a sample of young adults. Psychol. Addict. Behav. 30 (2016), 915–921.
27. Kandel, D.B., Hu, M.-C., Griesler, P.C., Schaffran, C., On the development of nicotine dependence in adolescence. Drug Alcohol Depend. 91 (2007), 26–39.
28. Kaynak, O., Meyers, K., Caldeira, K.M., Vincent, K.B., Winters, K.C., Arria, A.M., Relationships among parental monitoring and sensation seeking on the development of substance use disorder among college students. Addict. Behav. 38 (2013), 1457–1463.
29. Keller, C.J., Chen, E.C., Brodsky, K., Yoon, J.H., A case of butane hash oil (marijuana wax)–induced psychosis. Subst. Abuse 37 (2016), 384–386.
30. Kilmer, B., Caulkins, J.P., Midgette, G., Dahlkemper, L., MacCoun, R.J., Liccardo, P.R., Before the Grand Opening: Measuring Washington State's Marijuana Market in the Last Year Before Legalized Commercial Sales. 2013, Rand Corporation.
31. Krauss, M.J., Sowles, S.J., Mylvaganam, S., Zewdie, K., Bierut, L.J., Cavazos-Rehg, P.A., Displays of dabbing marijuana extracts on YouTube. Drug Alcohol Depend. 155 (2015), 45–51.
32. Lankenau, S.E., Fedorova, E.V., Reed, M., Schrager, S.M., Iverson, E., Wong, C.F., Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users. Drug Alcohol Depend. 170 (2017), 181–188.
33. Loflin, M., Earleywine, M., A new method of cannabis ingestion: the dangers of dabs?. Addict. Behav. 39 (2014), 1430–1433.
34. McGee, R., Williams, S., Poulton, R., Moffitt, T., A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction 95 (2000), 491–503.
35. Meehl, P.E., High school yearbooks: a reply to Schwarz. J. Abnorm. Psychol. 77 (1971), 143–148.
36. Meier, M.H., Hill, M.L., Small, P.J., Luthar, S.S., Associations of adolescent cannabis use with academic performance and mental health: a longitudinal study of upper middle class youth. Drug Alcohol Depend. 156 (2015), 207–212.
37. Morean, M.E., Kong, G., Camenga, D.R., Cavallo, D.A., Krishnan-Sarin, S., High school students’ use of electronic cigarettes to vaporize cannabis. Pediatrics 136 (2015), 611–616.
38. Morgan, C.J., Curran, H.V., Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br. J. Psychiatry 192 (2008), 306–307.
39. Nocon, A., Wittchen, H.-U., Pfister, H., Zimmermann, P., Lieb, R., Dependence symptoms in young cannabis users? A prospective epidemiological study. J. Psychiatr. Res. 40 (2006), 394–403.
40. Pierre, J.M., Gandal, M., Son, M., Cannabis-induced psychosis associated with high potency wax dabs. Schizophr. Res. 172 (2016), 211–212.
41. Raber, J.C., Elzinga, S., Kaplan, C., Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J. Toxicol. Sci. 40 (2015), 797–803.
42. Rubin, D.B., Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv. Outcomes Res. Method. 2 (2001), 169–188.
43. Schoeler, T., Petros, N., Di Forti, M., Klamerus, E., Foglia, E., Ajnakina, O., Gayer-Anderson, C., Colizzi, M., Quattrone, D., Behlke, I., Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study. Lancet Psychiatry 3 (2016), 947–953.
44. Simons, J.S., Dvorak, R.D., Merrill, J.E., Read, J.P., Dimensions and severity of marijuana consequences: development and validation of the Marijuana Consequences Questionnaire (MACQ). Addict. Behav. 37 (2012), 613–621.
45. Smart, R., Caulkins, J.P., Kilmer, B., Davenport, S., Midgette, G., Variation in cannabis potency and prices in a newly-legal market: evidence from 30 million cannabis sales in Washington State. Addiction, 2017, 10.1111/add.13886.
46. Smith, N., High potency cannabis: the forgotten variable. Addiction 100 (2005), 1558–1560.
47. Stogner, J.M., Miller, B.L., Assessing the dangers of dabbing: mere marijuana or harmful new trend?. Pediatrics 136 (2015), 1–3.
48. Stogner, J.M., Miller, B.L., The dabbing dilemma: a call for research on butane hash oil and other alternate forms of cannabis use. Subst. Abuse 36 (2015), 393–395.
49. van der Pol, P., Liebregts, N., de Graaf, R., Korf, D.J., van den Brink, W., van Laar, M., Validation of self-reported cannabis dose and potency: an ecological study. Addiction 108 (2013), 1801–1808.
50. van der Pol, P., Liebregts, N., Brunt, T., Amsterdam, J., Graaf, R., Korf, D.J., Brink, W., Laar, M., Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction 109 (2014), 1101–1109.
51. Volkow, N.D., Koob, G.F., McLellan, A.T., Neurobiologic advances from the brain disease model of addiction. N. Engl. J. Med. 374 (2016), 363–371.